GBT and Sickle Cell Disease Association of America to Host 10th Annual Sickle Cell Disease (SCD) Therapeutics ConferenceGlobeNewsWire • 09/08/21
Global Blood Therapeutics, Inc. (GBT) CEO Ted Love on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/04/21
Global Blood Therapeutics (GBT) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 08/03/21
New Data Supporting the Potential Use of Oxbryta® (voxelotor) in Children Ages 4 to 11 Years with Sickle Cell Disease Presented at European Hematology Association 2021 Virtual CongressGlobeNewsWire • 06/11/21
Global Blood (GBT) Up 0.1% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 06/04/21
GBT Announces Upcoming Data Presentations at European Hematology Association (EHA) 2021 Virtual CongressGlobeNewsWire • 05/12/21
Global Blood Therapeutics Q1 Earnings Miss Estimates On Disappointing Sales For Its Sickle-Cell Disease DrugBenzinga • 05/06/21
Global Blood Therapeutics, Inc. (GBT) CEO Dr. Ted Love on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/06/21
GBT and Sickle Cell Disease Association of America Kick Off “Lift Every Voice to Shine the Light on Sickle Cell” Spoken Word Contest in Honor of World Sickle Cell Day 2021GlobeNewsWire • 05/04/21
Will Global Blood Therapeutics (GBT) Report Negative Q1 Earnings? What You Should KnowZacks Investment Research • 04/28/21